Regencell Bioscience Holdings Ltd

Market Cap

$12B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$21.39+$0.85 (+4.14%)

Jun 8, 2026

52W High $78.0052W Low $10.36

Company Details

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and ...

CEO

—

IPO Date

Jul 16, 2021

Website

www.regencellbioscience.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$10M

EPS (Diluted)

Free Cash Flow

-$2M

Revenue / Share

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q3 2026

May 8, 2026

Q1 2026

Oct 31, 2025

FY 2025

Oct 31, 2025

Q2 2025

Dec 29, 2024

Q1 2025

Oct 25, 2024

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding